Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q3 2019 · 10-Q
Revenue$46.56K$46.56K−40.8% vs Q3 2018 Net Income-$1.03M-$1.03MN/M vs Q3 2018 EPS Diluted-$0.33-$0.33N/M vs Q3 2018 Operating Income-$885,637N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$823,515N/M Margins · derivedOperating margin-1902.1%−119.1 pt vs Q3 2018
Net margin-2220.4%+180.3 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end